1,2-dipalmitoylphosphatidylcholine has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, X; Lin, X; Wu, S | 1 |
| Cossu, F; Melis, G; Rombi, G | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Liver Neoplasms
| Article | Year |
|---|---|
Effect of Liposome-Encapsulated Zoledronic Acid on Microenvironment of Hepatocellular Carcinoma May Depend on the Ratio Between M1 and M2 Polarized Macrophages.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Drug Compounding; Female; Humans; Liposomes; Liver Neoplasms; Mice; Mice, Inbred BALB C; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; RAW 264.7 Cells; Tumor Burden; Tumor Microenvironment; Tumor-Associated Macrophages; Xenograft Model Antitumor Assays; Zoledronic Acid | 2020 |
mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibodies, Monoclonal; Brain Neoplasms; Breast Neoplasms; Drug Carriers; Female; Humans; Iodine Radioisotopes; Liposomes; Liver Neoplasms; Neoplasm Metastasis; Phosphatidylethanolamines; Radioimmunodetection; Technetium | 1993 |